Source: s3://data.kl3m.ai/documents/govinfo/USCOURTS/USCOURTS-caed-2_19-cv-02069/USCOURTS-caed-2_19-cv-02069-1/pdf.json

Nature of Suit Code: 365
Nature of Suit: Personal Injury - Product Liability
Cause of Action: 28:1332 Diversity-Product Liability

---

JOINT STIPULATION AND ORDER EXTENDING ALL DEADLINES PENDING DECISION BY THE JUDICIAL PANEL ON MULTIDISTRICT 

LITIGATION 

1 

2 

3 

4 

5 

6 

7 

8 

9 

10 

11 

12 

13 

14 

15 

16 

17 

18 

19 

20 

21 

22 

23 

24 

25 

26 

27 

28 

Amy O’Neill (Bar No. 294458) 

KING & SPALDING LLP 

621 Capitol Mall, Suite 1500 

Sacramento, CA 95814 

Telephone: (916) 321-4800 

Facsimile: (916) 321-4900 

Email: ao'neill@kslaw.com 

[Additional counsel listed on signature page(s)] 

Andrew T. Bayman (pro hac vice forthcoming) 

Robert B. Friedman (pro hac vice forthcoming) 

Julia Zousmer (pro hac vice forthcoming) 

1180 Peachtree Street, NE, Suite 1600 

Atlanta, GA 30309-3521 

Telephone: (404) 572-4600 

Facsimile: (404) 572-5100 

Email: abayman@kslaw.com 

Email: rfriedman@kslaw.com 

Email: jzousmer@kslaw.com 

Attorneys for Defendants 

Boehringer Ingelheim Pharmaceuticals, Inc 

UNITED STATES DISTRICT COURT 

FOR THE EASTERN DISTRICT OF CALIFORNIA 

SACRAMENTO DIVISION 

WALTER H. HANSEN, 

 Plaintiff, 

 v. 

BOEHRINGER INGELHEIM 

PHARMACEUTICALS, INC.; 

SANOFI US SERVICES INC.; 

CHATTEM, INC.; and 

GLAXOSMITHKLINE LLC, 

 Defendants. 

Civil Case No.: 2:19-cv-02069-KJM-AC 

JOINT STIPULATION AND ORDER 

EXTENDING ALL DEADLINES PENDING 

DECISION BY THE JUDICIAL PANEL 

ON MULTIDISTRICT LITIGATION 

 Plaintiff Walter H. Hansen and Defendants Sanofi US Services Inc. and Chattem, Inc. (the “Sanofi 

Defendants”); Boehringer Ingelheim Pharmaceuticals, Inc. (“BIPI”); Pfizer Inc. (“Pfizer”), and 

GlaxoSmithKline LLC (“GSK”) by and through their undersigned counsel, hereby jointly move the Court 

for an order extending all deadlines currently set in this case pending the determination of the Judicial 

Panel on Multidistrict Litigation (“JPML”) on a motion to transfer this case and other Zantac-related 

lawsuits to a multidistrict litigation (“MDL”). 

 The Parties hereby stipulate: 

Case 2:19-cv-02069-KJM-AC Document 30 Filed 02/03/20 Page 1 of 6
2 

JOINT STIPULATION AND ORDER EXTENDING ALL DEADLINES PENDING DECISION BY THE JUDICIAL PANEL ON MULTIDISTRICT 

LITIGATION 

1 

2 

3 

4 

5 

6 

7 

8 

9 

10 

11 

12 

13 

14 

15 

16 

17 

18 

19 

20 

21 

22 

23 

24 

25 

26 

27 

28 

 WHEREAS Plaintiffs filed the Complaint in the above-captioned action on October 15, 2019 (ECF 

No. 1); 

 WHEREAS the Court entered a Pretrial Scheduling Order on October 16, 2019, which, among 

other things, set a deadline for the parties to meet and confer pursuant to Federal Rule of Civil Procedure 

26 (ECF No. 3, at 2); 

 WHEREAS on November 22, 2019, the parties jointly stipulated to extend the time for Defendants 

to respond to the Complaint (ECF No. 5) to December 20, 2019; 

 WHEREAS on December 5, 2019, Defendants filed a Motion to Stay (ECF No. 8) proceedings 

pending decision by the JPML on a pending motion to transfer all Zantac-related personal injury and class 

action cases to a single jurisdiction for coordinated and consolidated pretrial proceedings in Case No 2924; 

 WHEREAS on December 19, 2019, the JPML scheduled a hearing date for the motion for transfer 

for January 30, 2020; 

 WHEREAS on December 17, 2019, the Court granted Defendants’ ex parte application to extend 

the deadline to respond to the Complaint to January 19, 2020 (ECF No. 14); 

 WHEREAS on January 17, 2020, after a hearing regarding Defendants’ Motion to Stay, the Court 

entered an Order instructing parties to meet and confer and file a joint statement and proposed schedule 

for moving the case forward within seven days (ECF No. 23); 

 WHEREAS the Court and the Parties discussed at the January 17, 2020 hearing, and Plaintiff 

stipulated, that Defendants would not be required to respond to the Complaint by January 19, 2010; 

WHEREAS on January 23, 2020, the Parties met, conferred, and agreed that all deadlines set by 

Federal Rule of Civil Procedure 26 and the Court’s Initial Pretrial Scheduling Order, as well as 

Defendants’ deadline to respond to the Complaint, should be extended pending a decision by the JPML. 

The parties further agreed to meet and confer within fourteen days of the JPML decision if the case is not 

transferred for inclusion in a MDL. 

WHEREAS Defendants’ Motion to Stay is currently pending before the Court; 

Case 2:19-cv-02069-KJM-AC Document 30 Filed 02/03/20 Page 2 of 6
3 

JOINT STIPULATION AND ORDER EXTENDING ALL DEADLINES PENDING DECISION BY THE JUDICIAL PANEL ON MULTIDISTRICT 

LITIGATION 

1 

2 

3 

4 

5 

6 

7 

8 

9 

10 

11 

12 

13 

14 

15 

16 

17 

18 

19 

20 

21 

22 

23 

24 

25 

26 

27 

28 

WHEREAS in order to conserve the resources of the Court and the parties and in light of the 

upcoming JPML hearing date for the motion for transfer, the Parties believe good cause exists for 

modifying the Initial Pretrial Scheduling Order; 

 NOW, THEREFORE, THE PARTIES HEREBY STIPULATE and request that the Court enter an 

order that the current deadlines set by Federal Rule of Civil Procedure 26 and the Court’s Initial Pretrial 

Scheduling Order, as well as the deadline for Defendants’ response to the Complaint, are hereby extended 

until at least fourteen days after the JPML issues its ruling. If this case is not transferred for inclusion in 

a MDL, the Parties shall meet-and-confer and file a revised statement and proposed schedule within 

fourteen days of the Judicial Panel on Multidistrict Litigation decision. 

Dated: January 24, 2020 Respectfully submitted, 

 By: /s/ Amy O’Neill 

Amy O’Neill (Bar No. 294458) 

KING & SPALDING LLP 

 621 Capitol Mall 

 Suite 1500 

Sacramento, CA 95814 

Telephone: (916) 321-4800 

Facsimile: (916) 321-4900 

Email: ao'neill@kslaw.com 

Andrew T. Bayman (pro hac vice forthcoming) 

Robert B. Friedman (pro hac vice forthcoming) 

Julia Zousmer (pro hac vice forthcoming) 

1180 Peachtree Street, NE, Suite 1600 

Atlanta, GA 30309-3521 

Telephone: (404) 572-4600 

Facsimile: (404) 572-5100 

Email: abayman@kslaw.com 

Email: rfriedman@kslaw.com 

Email: jzousmer@kslaw.com 

Attorneys for Defendant 

Boehringer Ingelheim Pharmaceuticals, Inc.

By: /s/Sharon Mayo (as authorized on 1/24/20) 

Sharon Mayo 

ARNOLD & PORTER 

KAYE SCHOLER LLP 

Three Embarcadero Center, 10th Floor 

San Francisco, CA 94111 

Case 2:19-cv-02069-KJM-AC Document 30 Filed 02/03/20 Page 3 of 6
4 

JOINT STIPULATION AND ORDER EXTENDING ALL DEADLINES PENDING DECISION BY THE JUDICIAL PANEL ON MULTIDISTRICT 

LITIGATION 

1 

2 

3 

4 

5 

6 

7 

8 

9 

10 

11 

12 

13 

14 

15 

16 

17 

18 

19 

20 

21 

22 

23 

24 

25 

26 

27 

28 

Tel: (415) 471-3100 

Fax: (415) 471-3400 

Email: oluoma.kas-osoka@arnoldporter.com 

 Anand Agneshwar (pro hac vice forthcoming) 

 ARNOLD & PORTER 

 KAYE SCHOLER LLP 

 250 West 55th Street 

 New York, NY 10019 

 Tel: (212) 836-8000 

 Fax: (212) 836-8689 

 Email: anand.agneshwar@arnoldporter.com 

 Daniel S. Pariser (pro hac vice forthcoming) 

 Paige H. Sharpe (pro hac vice forthcoming) 

Elliott Cruchley Mogul (pro hac vice forthcoming) 

ARNOLD & PORTER 

KAYE SCHOLER LLP 

601 Massachusetts Avenue, NW 

Washington, DC 20001 

Tel: (202) 942-5000 

Fax: (202) 942-5999 

 Email: daniel.pariser@arnoldporter.com 

 Email: paige.sharpe@arnoldporter.com 

 Email: elliott.mogul@arnoldporter.com 

 

Attorneys for Defendants 

Sanofi US Services Inc. and Chattem, Inc. 

. By: /s/ Jonathan Tam (as authorized on 1/24/20) 

Jonathan Tam (SBN 304143) 

DECHERT LLP 

One Bush Street, Suite 1600 

San Francisco, CA 94104-4446 

 Telephone: (415) 262-4500 

Facsimile: (415) 262-4555 

 Email: jonathan.tam@dechert.com 

Mark S. Cheffo (pro hac vice forthcoming) 

DECHERT LLP 

1095 Avenue of the Americas 

New York, NY 10036 

 Telephone: (212) 698-3500 

Facsimile: (212) 698-3599 

Email: mark.cheffo@dechert.com 

Will W. Sachse (pro hac vice forthcoming) 

DECHERT LLP 

Cira Centre, 2929 Arch Street 

Philadelphia, PA 19104 

 Telephone: (215) 994-4000 

Facsimile: (215) 994-2222 

 Email: will.sachse@dechert.com 

Attorneys for Defendant GlaxoSmithKline LLC 

Case 2:19-cv-02069-KJM-AC Document 30 Filed 02/03/20 Page 4 of 6
5 

JOINT STIPULATION AND ORDER EXTENDING ALL DEADLINES PENDING DECISION BY THE JUDICIAL PANEL ON MULTIDISTRICT 

LITIGATION 

1 

2 

3 

4 

5 

6 

7 

8 

9 

10 

11 

12 

13 

14 

15 

16 

17 

18 

19 

20 

21 

22 

23 

24 

25 

26 

27 

28 

 

By: /s/ Robert Brent Wisner (as authorized on 1/24/20) 

 Robert Brent Wisner 

 Pedram Esfandiary 

 Timothy A. Loranger 

 BAUM HEDLUND ARISTEI AND GOLDMAN 

 10940 Wilshire Blvd., 17th Floor 

 Los Angeles, CA 90024 

 Tel: 310-207-3233 

 Fax: 310-820-7444 

 Email: rbwisner@baumhedlundlaw.com 

 Email: pesfandiary@baumhedlundlaw.com 

 Email: tloranger@baumhedlundlaw.com 

 Attorneys for Plaintiff Walter H Hansen 

 

Case 2:19-cv-02069-KJM-AC Document 30 Filed 02/03/20 Page 5 of 6
6 

JOINT STIPULATION AND ORDER EXTENDING ALL DEADLINES PENDING DECISION BY THE JUDICIAL PANEL ON MULTIDISTRICT 

LITIGATION 

1 

2 

3 

4 

5 

6 

7 

8 

9 

10 

11 

12 

13 

14 

15 

16 

17 

18 

19 

20 

21 

22 

23 

24 

25 

26 

27 

28 

ORDER 

 Pursuant to stipulation, and good cause appearing, it is hereby ORDERED that the parties’ 

deadlines required set by Federal Rule of Civil Procedure 26 and the Court’s Initial Pretrial Scheduling 

Order are hereby extended until fourteen (14) days after the Judicial Panel on Multidistrict Litigation 

(“JPML”) issues its ruling whether to form a Multidistrict Litigation. If this case is not transferred for 

inclusion in a multidistrict litigation, the Parties shall meet-and-confer and file a revised statement 

within fourteen (14) days of the Judicial Panel on Multidistrict Litigation decision. 

IT IS SO ORDERED. 

DATED: January 31, 2020. 

Case 2:19-cv-02069-KJM-AC Document 30 Filed 02/03/20 Page 6 of 6